Antidepressant-induced liver injury: a review for clinicians
about
A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association AnalysisLiver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric SettingsA systematic review of agomelatine-induced liver injuryAgomelatine in the treatment of major depressive disorder: an assessment of benefits and risksHepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre.Efficacy and tolerability of agomelatine in the treatment of depressionHepatocellular carcinoma and antidepressants: a nationwide population-based study.Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group.Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance StudyEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in RatsDrug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance ProgramThe Effect of Chronic Mild Stress and Imipramine on the Markers of Oxidative Stress and Antioxidant System in Rat Liver.Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells.Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants.Management of treatment-resistant depression in children and adolescents.Agomelatine for the treatment of generalized anxiety disorder.Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily Practice.Clinical preference for factors in treatment of geriatric depression.Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.Liver enzyme levels in adolescent patients treated with buprenorphine and additional psychotropic agents.Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic Cells.Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression.The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats.Agomelatine-induced liver injury in a patient with choledocholithiasis.Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population.The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury.Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-κB.The assessment and management of pain in cirrhosis.Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.A case of probable oxybutynin-induced increase in liver enzymes
P2860
Q28551628-F84A9B97-1DBD-4C53-91F1-601B441057A9Q28552027-70304808-AE1D-43CC-A77E-E48B41E337E8Q28648515-C9E399F7-2EF4-4138-B061-7AECACFCA1D0Q28651497-9D04484C-DC8F-4430-9D28-1B964184CCBAQ30887490-78E5601A-D087-40B0-924D-D5600B95D0F1Q33583450-69615FC8-953B-4AB3-85ED-9B5662761650Q33728349-05C97628-4D73-4FA3-A297-E60EE1EFF9ADQ35169141-2F8C7548-9CF3-404E-9D02-B255E4613305Q35684831-CC8B7577-5146-49A4-8E86-2C71A45C814EQ35754726-A1FF362A-B714-4B70-9816-E7CE679F6FE0Q35809210-8A977A58-E726-4760-BCBA-C2CD27E2DE5AQ35819331-9B259170-D6F0-42EC-A89E-86E198711712Q36176479-FF3919BD-9824-4C82-8DAF-CF78E5983057Q36852416-2FB30C91-55FC-446B-885D-CFC8425876D1Q37099353-82B8B1B1-9E76-455E-B8DB-BF1A10DBBBFFQ37145683-0D2B7B7B-D1B0-48A6-A1FE-6786DBEFE1B3Q37625519-1931CA5A-99EC-45FD-99E7-48B20D2A2E49Q38246706-E736F564-C79B-4B45-9D2E-CAF178F18AABQ38247062-692D2CAD-DDD3-447A-81BF-80E35E9783F7Q38668480-4E8F8F73-E697-49C6-85B7-4D005BCDFD2AQ38876395-0D538663-2060-420F-8FE2-8F9ED6E29F97Q38953673-FC28B6E1-17E4-4422-90C4-6A0A5349CBF8Q39063267-B0772FD0-67DF-483F-8C54-D38A9276A88FQ41233907-ED3B7A65-7A43-4834-AA3E-DB6E7EBD0E72Q41711349-9E747C7C-1414-44DB-B842-EB594E24C5A1Q47171631-56FE62E5-0EFA-4088-B0C8-F68D1FC68506Q47604739-13C6EEDB-3610-4AC9-BF1D-682889A1EA79Q48048163-E15F29B9-674A-4515-8EE3-21C68E3891C3Q48065499-623B7A7A-6E1B-4481-86A5-D33371A43AE7Q48187972-9F6E0E9E-D76B-4E64-9AEA-D5A7448FE686Q48300860-3879C2C1-D6E4-4B4F-950E-793EF3CB6580Q48349259-C5636A39-79DC-4898-A118-50CC4FB34D19Q48557558-C48751F9-2CFA-450E-9806-70942B82B732Q52351014-BBB768CA-96A5-4F33-8C5E-028C8EC65704Q52681690-A4FA9E9C-CB6E-4E1A-A0B7-46CC717704CDQ55054440-F3324A05-CE20-42DA-BF46-A77E05F08732Q58754646-4A1A118F-3715-4D88-A30F-A2C7861EEE49
P2860
Antidepressant-induced liver injury: a review for clinicians
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antidepressant-induced liver injury: a review for clinicians
@ast
Antidepressant-induced liver injury: a review for clinicians
@en
Antidepressant-induced liver injury: a review for clinicians
@nl
type
label
Antidepressant-induced liver injury: a review for clinicians
@ast
Antidepressant-induced liver injury: a review for clinicians
@en
Antidepressant-induced liver injury: a review for clinicians
@nl
prefLabel
Antidepressant-induced liver injury: a review for clinicians
@ast
Antidepressant-induced liver injury: a review for clinicians
@en
Antidepressant-induced liver injury: a review for clinicians
@nl
P2093
P3181
P1476
Antidepressant-induced liver injury: a review for clinicians
@en
P2093
Cosmin Sebastian Voican
Emmanuelle Corruble
Gabriel Perlemuter
Sylvie Naveau
P304
P3181
P356
10.1176/APPI.AJP.2013.13050709
P407
P577
2014-04-01T00:00:00Z